Results 101 to 110 of about 5,276 (179)

Differentiation of MPNSTs from benign neurofibromas in neurofibromatosis patients using ADC and SUV biomarkers in children and young adults. [PDF]

Curr Probl Diagn Radiol
Shokri Varniab Z, Lokesha YU, Qi J, Wong J, Iv M, Hawk E, Daldrup-Link H.   +6 more
europepmc   +1 more source

Single-cell transcriptomic profiling of malignant peripheral nerve sheath tumors. [PDF]

Neurooncol Adv
Gui C, Bunda S, Li M, Singh O, Zadeh G, Suppiah S.   +5 more
europepmc   +1 more source

TEAD inhibitors synergize with MEK, SHP2 and mTOR inhibitors in NF1 and NF2 cell lines. [PDF]

MicroPubl Biol
Yang Y, Gurunathan S, Schechter S, Field J.   +3 more
europepmc   +1 more source

Malignant peripheral nerve sheath tumors arising in SMARCB1-associated schwannomatosis: illustrative cases. [PDF]

J Neurosurg Case Lessons
Khalilullah T, Yang X, Yao J, Ghaith AK, Khalifeh JM, Azad TD, Ahmed AK, Xia Y, Theodore N, Romo CG, Wolinsky JP, Belzberg AJ, Lubelski D.   +12 more
europepmc   +1 more source

IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors. [PDF]

J Clin Invest
Zhu I, Chien J, Rech GE, Mirchia K, Pan S, Miller K, Pak J, Wustrack R, Monga V, Braunstein SE, Adams MD, Jacques L, Pekmezci M, Liu SJ, Vasudevan HN.   +14 more
europepmc   +1 more source

Malignant Peripheral Nerve Sheath Tumor of the Pancreas: A Case Report and Updated Review of Related Literature. [PDF]

Acta Med Philipp
De Castro LRO, Tatoy VF, Capaya SI, Fernando GY.   +3 more
europepmc   +1 more source

Pelvic Malignant Peripheral Nerve Sheath Tumor Revealing Previously Undiagnosed Familial Neurofibromatosis Type 1 in a Nine-Year-Old Girl: A Case Report. [PDF]

Cureus
Zahiri H, Ghanam A, Benhachem M, Azizi M, Rkain M.   +4 more
europepmc   +1 more source

Primary pulmonary MPNST‒A rare case report [PDF]

International Clinical Pathology Journal, 2018
openaire   +1 more source

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets. [PDF]

Acta Neuropathol Commun
Brunet A, Coulpier F, Onfroy A, Sako N, Radomska KJ, Aftimos V, Lacroix L, Briand-Suleau A, Maille P, Hermeziu O, Laurendeau I, Pasmant E, Wolkenstein P, Topilko P, Ortonne N.   +14 more
europepmc   +1 more source

Personalized medicine strategy for MPNSTs: using precision oncology on PDOX models to inform tumor boards. [PDF]

J Transl Med
Ortega-Bertran S, Fernández-Rodríguez J, Magallón-Lorenz M, Creus-Bachiller E, Uriarte-Arrazola I, Mazuelas H, Garraus M, Carrió M, Gel B, Rovira C, Alvarez M, Villanueva A, Castaneda A, Salvador H, Serra E, Lázaro C.   +15 more
europepmc   +1 more source